Implication of Intra-Tumor Heterogeneity on Colorectal Cancer Response to MEK Inhibition
Intra-tumor heterogeneity (ITH) poses a major obstacle in cancer therapy. In colorectal cancer (CRC), mutations in the transforming growth factor-β/bone morphogenetic protein (TGF-β/BMP) pathway, especially in the SMAD4 gene, have been correlated with decreased overall survival and are suspected to...
Main Author: | Christian Regenbrecht |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Biology and Life Sciences Forum |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-9976/21/1/19 |
Similar Items
-
Overview on Clinical Relevance of Intra-Tumor Heterogeneity
by: Giorgio Stanta, et al.
Published: (2018-04-01) -
Editorial: Tumor Heterogeneity
by: Stefano La Rosa, et al.
Published: (2019-07-01) -
Mutant-Allele Tumor Heterogeneity, a Favorable Biomarker to Assess Intra-Tumor Heterogeneity, in Advanced Lung Adenocarcinoma
by: Xiaoxuan Wu, et al.
Published: (2022-07-01) -
Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications
by: George D. Cresswell, et al.
Published: (2016-07-01) -
Intra-Tumoral Genomic Heterogeneity in Rectal Cancer: Mutational Status Is Dependent on Preoperative Biopsy Depth and Location
by: Floris A. Vuijk, et al.
Published: (2021-05-01)